There's a new DNA test for babies that can check for 193 genetic diseases

DNA.
(Image credit: iStock.)

Forget counting fingers and toes — new parents may soon be able to analyze their baby's genes.

MIT Technology Review reported Wednesday that the health information company Sema4 has developed a DNA test that screens babies for almost 200 genetic diseases. The test, which costs $649, is intended to expand on existing screeners recommended by the U.S. government, which only flag roughly 30 genetic disorders. With the ability to identify a greater number of abnormalities in their baby's first days — including ones that otherwise may not yield accurate diagnoses for years — parents can "get a better understanding of the health of your child," said Eric Schadt, the CEO of Sema4.

The test uses saliva procured from a baby's cheek to screen for problematic genetic alterations, as well as potential reactions to a range of medications usually given to young children, the Review says. Sema4's test has not yet been approved for coverage by insurance companies, which means dutiful parents will have to pick up the tab on their own for the time being.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

The potential for expanded health knowledge isn't without its consequences. Some of the genetic abnormalities Sema4 is designed to detect may not cause symptoms for years, the Review notes, and "sometimes a child can carry a mutation but never develop the corresponding disease" at all. That means that overanxious parents may subject their children to expensive or intrusive medical procedures based on Sema4's results that may not actually be necessary. Laura Hercher, a genetics professor at Sarah Lawrence College, cautioned: "For many families, this is the kind of thing that can open up a can of worms where it doesn't end up necessarily benefiting the parent or child."

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us